Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • bristol myers

    Tag: bristol myers

    You Searched For "bristol myers"
    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    Medical Dialogues Bureau2 Jan 2020 9:18 AM GMT
    New Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    Medical Dialogues Bureau24 Dec 2019 4:15 AM GMT
    Sales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
    Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche

    Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche

    Medical Dialogues Bureau25 Nov 2019 3:30 AM GMT
    Median overall survival for patients with unresectable hepatocellular carcinoma (HCC), or that which cannot be surgically removed, getting Tecentriq...
    Bristol-Myers blockbuster Opdivo fails to meet goal of brain tumour study

    Bristol-Myers blockbuster Opdivo fails to meet goal of brain tumour study

    Medical Dialogues Bureau8 Sep 2019 3:45 AM GMT
    The drug, Opdivo, when used along with the current standard of care for glioblastoma multiforme, did not prevent cancer from spreading when compared...
    Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

    Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

    Medical Dialogues Bureau28 July 2019 3:47 AM GMT
    Sales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
    Exelixis drug improves overall survival in liver cancer patients

    Exelixis drug improves overall survival in liver cancer patients

    Ruby Khatun Khatun21 Oct 2017 3:42 AM GMT
    Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert...
    Bristols drug cocktail cuts kidney cancer death risk 37 percent

    Bristols drug cocktail cuts kidney cancer death risk 37 percent

    Ruby Khatun Khatun14 Sep 2017 3:55 AM GMT
    MADRID: A combination of two Bristol-Myers Squibb immunotherapy drugs cut the risk of death by 37 percent in a key group of kidney cancer patients,...
    After melanoma surgery, Bristols Opdivo offers new care standard

    After melanoma surgery, Bristols Opdivo offers new care standard

    Ruby Khatun Khatun12 Sep 2017 3:45 AM GMT
    MADRID: Bristol-Myers Squibb's immunotherapy drug Opdivo is a better and safer option than its older medicine Yervoy for treating melanoma patients...
    Bristol-Myers stops kidney cancer drug test after early success

    Bristol-Myers stops kidney cancer drug test after early success

    Ruby Khatun Khatun11 Sep 2017 5:18 AM GMT
    Bristol-Myers Squibb Co said on Thursday the success of its combination therapy to improve overall survival in kidney cancer patients helped it end...
    Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity

    Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity

    Ruby Khatun Khatun28 Aug 2017 7:35 AM GMT
    FRANKFURT: Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X